HEADER HYDROLASE/HYDROLASE INHIBITOR 02-MAR-94 1SCN TITLE INACTIVATION OF SUBTILISIN CARLSBERG BY N-(TERT-BUTOXYCARBONYL-ALANYL- TITLE 2 PROLYL-PHENYLALANYL)-O-BENZOL HYDROXYLAMINE: FORMATION OF COVALENT TITLE 3 ENZYME-INHIBITOR LINKAGE IN THE FORM OF A CARBAMATE DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUBTILISIN CARLSBERG; COMPND 3 CHAIN: E; COMPND 4 EC: 3.4.21.62; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS LICHENIFORMIS; SOURCE 3 ORGANISM_TAXID: 1402 KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX, SERINE PROTEINASE EXPDTA X-RAY DIFFRACTION AUTHOR A.C.U.STEINMETZ,H.-U.DEMUTH,D.RINGE REVDAT 6 29-NOV-17 1SCN 1 HELIX REVDAT 5 13-JUL-11 1SCN 1 VERSN REVDAT 4 25-AUG-09 1SCN 1 SOURCE REVDAT 3 24-FEB-09 1SCN 1 VERSN REVDAT 2 01-APR-03 1SCN 1 JRNL REVDAT 1 31-AUG-94 1SCN 0 JRNL AUTH A.C.STEINMETZ,H.U.DEMUTH,D.RINGE JRNL TITL INACTIVATION OF SUBTILISIN CARLSBERG BY JRNL TITL 2 N-((TERT-BUTOXYCARBONYL)ALANYLPROLYLPHENYLALANYL) JRNL TITL 3 -O-BENZOLHYDROXYL- AMINE: FORMATION OF A COVALENT JRNL TITL 4 ENZYME-INHIBITOR LINKAGE IN THE FORM OF A CARBAMATE JRNL TITL 5 DERIVATIVE. JRNL REF BIOCHEMISTRY V. 33 10535 1994 JRNL REFN ISSN 0006-2960 JRNL PMID 8068694 JRNL DOI 10.1021/BI00200A040 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 17548 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1919 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 141 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.010 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 3.200 ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1SCN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000176320. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 38.25000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 26.70000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.70000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 26.70000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.25000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.70000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA E 276 REMARK 465 PRO E 277 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 C3 0EF E 447 O HOH E 852 4477 0.79 REMARK 500 C1 0EF E 447 O HOH E 650 4477 1.07 REMARK 500 CG ARG E 249 C2 0EF E 447 4577 1.38 REMARK 500 CD ARG E 249 C2 0EF E 447 4577 1.44 REMARK 500 CT 0EF E 447 O HOH E 852 4477 1.62 REMARK 500 NE ARG E 249 C2 0EF E 447 4577 1.68 REMARK 500 NE ARG E 249 C3 0EF E 447 4577 1.72 REMARK 500 NE ARG E 249 CT 0EF E 447 4577 1.91 REMARK 500 O HOH E 859 O HOH E 879 3757 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS E 15 CE LYS E 15 NZ 0.219 REMARK 500 GLU E 54 CD GLU E 54 OE1 0.072 REMARK 500 GLU E 197 CD GLU E 197 OE1 0.071 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP E 32 CB - CG - OD1 ANGL. DEV. = -8.4 DEGREES REMARK 500 ASP E 32 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 PHE E 50 CB - CG - CD1 ANGL. DEV. = 4.7 DEGREES REMARK 500 ASP E 60 CB - CG - OD1 ANGL. DEV. = -5.9 DEGREES REMARK 500 VAL E 88 CG1 - CB - CG2 ANGL. DEV. = -10.1 DEGREES REMARK 500 SER E 98 CB - CA - C ANGL. DEV. = -12.2 DEGREES REMARK 500 ASP E 120 CB - CG - OD1 ANGL. DEV. = -6.2 DEGREES REMARK 500 ASP E 120 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP E 140 CB - CG - OD1 ANGL. DEV. = 7.0 DEGREES REMARK 500 ASP E 140 CB - CG - OD2 ANGL. DEV. = -7.1 DEGREES REMARK 500 SER E 159 N - CA - CB ANGL. DEV. = 10.0 DEGREES REMARK 500 TYR E 167 CB - CA - C ANGL. DEV. = -13.2 DEGREES REMARK 500 TYR E 167 CB - CG - CD1 ANGL. DEV. = -6.0 DEGREES REMARK 500 ASP E 172 CB - CG - OD2 ANGL. DEV. = -6.8 DEGREES REMARK 500 ASP E 181 CB - CG - OD1 ANGL. DEV. = 10.9 DEGREES REMARK 500 ASP E 181 CB - CG - OD2 ANGL. DEV. = -11.7 DEGREES REMARK 500 ARG E 249 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG E 249 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 SER E 259 N - CA - CB ANGL. DEV. = -9.2 DEGREES REMARK 500 TYR E 263 CB - CG - CD2 ANGL. DEV. = -4.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP E 32 -146.16 -163.53 REMARK 500 ALA E 73 30.40 -147.55 REMARK 500 ASN E 77 -142.63 -153.63 REMARK 500 VAL E 81 -168.36 -117.80 REMARK 500 ASP E 181 -169.77 -102.92 REMARK 500 THR E 213 -158.74 -129.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA E 401 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP E 41 OD2 REMARK 620 2 ASP E 41 OD1 50.1 REMARK 620 3 VAL E 81 O 80.2 127.0 REMARK 620 4 GLN E 2 NE2 158.6 150.6 81.5 REMARK 620 5 ASN E 77 OD1 127.7 82.8 150.2 69.0 REMARK 620 6 THR E 79 O 86.5 93.1 102.0 86.6 73.1 REMARK 620 7 LEU E 75 O 113.4 96.7 86.3 76.1 90.4 159.6 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA E 403 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH E 640 O REMARK 620 2 HOH E 637 O 123.9 REMARK 620 3 ALA E 37 O 174.2 54.9 REMARK 620 4 HOH E 572 O 60.1 63.8 117.9 REMARK 620 5 LEU E 42 O 89.3 64.6 94.8 65.5 REMARK 620 6 HIS E 39 O 81.3 134.9 103.4 127.4 80.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA E 402 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU E 195 O REMARK 620 2 GLU E 197 OE1 112.5 REMARK 620 N 1 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-(TERT-BUTOXYCARBONYL)-L-ALANYL-N-[(1R)-1- REMARK 630 (CARBOXYAMINO)-2-PHENYLETHYL]-L-PROLINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0EF E 447 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: BOC ALA PRO APE REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0EF E 447 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA E 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA E 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA E 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: ACT REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: CATALYTIC TRIAD IN THE ENZYME ACTIVE SITE REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE USED IN THIS ENTRY IS THE SAME AS USED IN PDB REMARK 999 ENTRIES 1SCA AND 1SCB. DBREF 1SCN E 1 275 UNP P00780 SUBT_BACLI 106 379 SEQADV 1SCN SER E 103 UNP P00780 THR 207 CONFLICT SEQADV 1SCN ALA E 129 UNP P00780 PRO 233 CONFLICT SEQADV 1SCN ASN E 158 UNP P00780 SER 262 CONFLICT SEQADV 1SCN SER E 161 UNP P00780 ASN 265 CONFLICT SEQADV 1SCN ASN E 212 UNP P00780 SER 316 CONFLICT SEQRES 1 E 276 ALA GLN THR VAL PRO TYR GLY ILE PRO LEU ILE LYS ALA SEQRES 2 E 276 ASP LYS VAL GLN ALA GLN GLY PHE LYS GLY ALA ASN VAL SEQRES 3 E 276 LYS VAL ALA VAL LEU ASP THR GLY ILE GLN ALA SER HIS SEQRES 4 E 276 PRO ASP LEU ASN VAL VAL GLY GLY ALA SER PHE VAL ALA SEQRES 5 E 276 GLY GLU ALA TYR ASN THR ASP GLY ASN GLY HIS GLY THR SEQRES 6 E 276 HIS VAL ALA GLY THR VAL ALA ALA LEU ASP ASN THR THR SEQRES 7 E 276 GLY VAL LEU GLY VAL ALA PRO SER VAL SER LEU TYR ALA SEQRES 8 E 276 VAL LYS VAL LEU ASN SER SER GLY SER GLY SER TYR SER SEQRES 9 E 276 GLY ILE VAL SER GLY ILE GLU TRP ALA THR THR ASN GLY SEQRES 10 E 276 MET ASP VAL ILE ASN MET SER LEU GLY GLY ALA SER GLY SEQRES 11 E 276 SER THR ALA MET LYS GLN ALA VAL ASP ASN ALA TYR ALA SEQRES 12 E 276 ARG GLY VAL VAL VAL VAL ALA ALA ALA GLY ASN SER GLY SEQRES 13 E 276 ASN SER GLY SER THR ASN THR ILE GLY TYR PRO ALA LYS SEQRES 14 E 276 TYR ASP SER VAL ILE ALA VAL GLY ALA VAL ASP SER ASN SEQRES 15 E 276 SER ASN ARG ALA SER PHE SER SER VAL GLY ALA GLU LEU SEQRES 16 E 276 GLU VAL MET ALA PRO GLY ALA GLY VAL TYR SER THR TYR SEQRES 17 E 276 PRO THR ASN THR TYR ALA THR LEU ASN GLY THR SER MET SEQRES 18 E 276 ALA SER PRO HIS VAL ALA GLY ALA ALA ALA LEU ILE LEU SEQRES 19 E 276 SER LYS HIS PRO ASN LEU SER ALA SER GLN VAL ARG ASN SEQRES 20 E 276 ARG LEU SER SER THR ALA THR TYR LEU GLY SER SER PHE SEQRES 21 E 276 TYR TYR GLY LYS GLY LEU ILE ASN VAL GLU ALA ALA ALA SEQRES 22 E 276 GLN ALA PRO HET 0EF E 447 31 HET CA E 401 1 HET NA E 402 1 HET CA E 403 1 HETNAM 0EF N-(TERT-BUTOXYCARBONYL)-L-ALANYL-N-[(1R)-1- HETNAM 2 0EF (CARBOXYAMINO)-2-PHENYLETHYL]-L-PROLINAMIDE HETNAM CA CALCIUM ION HETNAM NA SODIUM ION HETSYN 0EF N-(TERT-BUTOXYCARBONYL-ALANYL-PROLYL-PHENYLALANYL)-O- HETSYN 2 0EF BENZOYL HYDROXYLAMINE FORMUL 2 0EF C22 H32 N4 O6 FORMUL 3 CA 2(CA 2+) FORMUL 4 NA NA 1+ FORMUL 6 HOH *141(H2 O) HELIX 1 H1 TYR E 6 ILE E 11 1 6 HELIX 2 H2 LYS E 12 GLN E 19 1 8 HELIX 3 H3 GLY E 63 ALA E 74 1 12 HELIX 4 H4 SER E 103 ASN E 117 1 15 HELIX 5 H5 SER E 132 ARG E 145 1 14 HELIX 6 H6 THR E 220 HIS E 238 1PERTURBATION AT SER E 221 19 HELIX 7 H7 SER E 242 THR E 253 1 12 HELIX 8 H8 ASN E 269 ALA E 274 1 6 SHEET 1 SH1 8 ASN E 43 PHE E 50 0 SHEET 2 SH1 8 SER E 89 VAL E 95 1 O LEU E 90 N VAL E 45 SHEET 3 SH1 8 VAL E 26 ASP E 32 1 O VAL E 28 N TYR E 91 SHEET 4 SH1 8 ASP E 120 MET E 124 1 N ASP E 120 O LYS E 27 SHEET 5 SH1 8 VAL E 148 ALA E 153 1 N VAL E 150 O ILE E 122 SHEET 6 SH1 8 ILE E 175 VAL E 180 1 N ILE E 175 O VAL E 149 SHEET 7 SH1 8 GLU E 197 GLY E 202 1 N GLY E 202 O VAL E 180 SHEET 8 SH1 8 LYS E 265 ILE E 268 1 O GLY E 266 N MET E 199 LINK CA CA E 401 OD2 ASP E 41 1555 1555 2.58 LINK CA CA E 401 OD1 ASP E 41 1555 1555 2.56 LINK CA CA E 401 O VAL E 81 1555 1555 2.37 LINK CA CA E 401 NE2 GLN E 2 1555 1555 2.42 LINK CA CA E 401 OD1 ASN E 77 1555 1555 2.47 LINK CA CA E 401 O THR E 79 1555 1555 2.40 LINK CA CA E 401 O LEU E 75 1555 1555 2.39 LINK CA CA E 403 O HOH E 640 1555 1555 3.29 LINK CA CA E 403 O HOH E 637 1555 1555 3.17 LINK CA CA E 403 O ALA E 37 1555 1555 2.70 LINK CA CA E 403 O HOH E 572 1555 1555 3.16 LINK CA CA E 403 O LEU E 42 1555 1555 2.70 LINK CA CA E 403 O HIS E 39 1555 1555 2.41 LINK O GLU E 195 NA NA E 402 1555 1555 2.77 LINK OE1 GLU E 197 NA NA E 402 1555 1555 2.96 LINK OG SER E 221 C6 0EF E 447 1555 1555 1.43 CISPEP 1 TYR E 167 PRO E 168 0 16.31 CISPEP 2 PRO E 210 THR E 211 0 -11.23 SITE 1 AC1 18 SER E 99 GLY E 100 LEU E 126 GLY E 127 SITE 2 AC1 18 GLY E 128 ALA E 152 GLY E 154 ASN E 155 SITE 3 AC1 18 SER E 221 GLN E 245 ARG E 249 HOH E 650 SITE 4 AC1 18 HOH E 659 HOH E 662 HOH E 802 HOH E 850 SITE 5 AC1 18 HOH E 852 HOH E 861 SITE 1 AC2 6 GLN E 2 ASP E 41 LEU E 75 ASN E 77 SITE 2 AC2 6 THR E 79 VAL E 81 SITE 1 AC3 4 VAL E 174 ALA E 176 GLU E 195 GLU E 197 SITE 1 AC4 4 ALA E 37 SER E 38 HIS E 39 LEU E 42 SITE 1 ACT 3 ASP E 32 HIS E 64 SER E 221 CRYST1 76.500 55.400 53.400 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013072 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018051 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018727 0.00000